By Andrea Dwyer, BS; Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN; Brenda Nevidjon, MSN, RN, FAAN; Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG; Sally Werner, RN, BSN, MSHA; Burt Zweigenhaft, PhD, D.Litt
Nurses are on the frontlines of healthcare delivery. In this panel, distinguished nursing professionals discussed topics and issues that have arisen during the pandemic. Led by healthcare educator Lillie D. Shockney, the comprehensive panel covered some of the myriad issues nurse navigators confront now, including rising cancer rates in an aging population, and a decline in numbers of oncology nurses and oncologists.
Watch Video
Watch Video
By Deborah Kamin, RN, PhD; Ted Okon, MBA; John O’Brien, PharmD, MPH; Jayson Slotnik, JD, MPH; Burt Zweigenhaft, PhD, D.Litt
The federal government is an active participant in shaping healthcare policy and delivering care. The panelists in this session addressed the government’s response to COVID-19 and weighed in on some of the issues that their agencies frequently encountered as medical practices grapple with the new normal.
Watch Video
Watch Video
By Murray Harber; Art Taft; Karen van Caulil, PhD; F. Randy Vogenberg, PhD, RPh, FASHP; Burt Zweigenhaft, PhD, D.Litt
Employers continue to face significant challenges as they strive to provide healthcare coverage for their employees during the COVID-19 pandemic. In this discussion, moderated by Burt Zweigenhaft, PhD, D.Litt, a panel of experts explore solutions for some of the issues arising in a vastly changed healthcare market, and strategies for improving the way in which health benefits are conceived and implemented.
Watch Video
Watch Video
By Bob Gold; Karen Keown, RN; Rick Lee; Brian Leyland-Jones, MD; Chevon Rariy, MD; Burt Zweigenhaft, PhD, D.Litt
Telehealth continues to play a critical role in providing healthcare services to patients during the COVID-19 pandemic. In a webcast titled COVID-19: Impact on Telehealth, Rick Lee, Executive Chairman, Healthy Platforms and CancerLife, along with a panel of experts, discussed the benefits and ongoing challenges associated with the use of telemedicine and the far-reaching impact of this technology beyond the current crisis.
Watch Video
Watch Video
By Rob Butcher; Craig Eagle, MD; Tom Lynch, MD; Maurie Markman, MD; Julie Saba, MD, PhD; Richard Schilsky, MD, FACP, FSCT, FASCO; Jedd Wolchok, MD, PhD, FASCO; Burt Zweigenhaft, PhD, D.Litt
Researchers and clinical investigators are facing a series of unprecedented challenges as they adjust to necessary changes to their work environment resulting from the COVID-19 crisis. In this discussion, moderated by Rob Butcher, CEO, Swim Across America, a panel of researchers discuss the impact of the pandemic on conditions in laboratories, and how graduate students have had to adjust to interruptions in their career trajectories.
Watch Video
Watch Video
By Michael Ganio, PharmD; Chris Marcum, PharmD; Ali McBride, PharmD, MBA; Stacey McCullough, PharmD; Bhavesh Shah, RPh, BCOP; Burt Zweigenhaft, PhD, D.Litt
In this discussion, moderated by Niesha Griffith, RPh, MS, FASHP, CPO (interim), a panel of oncology pharmacists discuss the impact of the COVID-19 pandemic on their practices, the increase in the use of new technologies as a result of recent events, and how the influx of patients expected in the coming weeks will affect their daily operations.
Watch Video
Watch Video
By Roy Baynes, MD, PhD; Rena Goins; Mark Hagler, MBA; Bruce Wilson; Bryon Wornson; Burt Zweigenhaft, PhD, D.Litt
Pharmaceutical support and innovation are vital to the effective treatment of patients with cancer. In this discussion, moderated by Burt Zweigenhaft, PhD, D.Litt, a panel of experts discussed the importance of maintaining an adequate supply of medicines for patients, and the need for philanthropic programs to ensure patients will be able to continue their medications, even if they lose their health insurance.
Watch Video
Watch Video
By Lucio Gordan, MD; Ted Okon, MBA; Debra Patt, MD, PhD, MBA; Jeff Patton, MD; Burt Zweigenhaft, PhD, D.Litt
Large community care centers remain committed to providing necessary treatment to patients with cancer during the COVID-19 pandemic. In this discussion, moderated by Ted Okon, MBA, a panel of experts discuss the ongoing challenges that oncology providers face as they navigate an evolving healthcare ecosystem, and provide valuable insights on how practices may continue to deliver care in the months ahead.
Watch Video
Watch Video
By Al B. Benson III, MD; Linda D. Bosserman, MD, FACP; Christian Downs, MHA, JD; Julian Schink, MD; Burt Zweigenhaft, PhD, D.Litt
As a result of the ongoing COVID-19 pandemic, comprehensive cancer care centers have been tasked with significantly altering their strategies for the delivery of care. In this discussion, moderated by Burt Zweigenhaft, PhD, D.Litt, a panel of experts discuss some of the changes that have already been implemented at their centers and future considerations for healthcare systems as they focus on providing safe and effective care on the road to recovery.
Watch Video
Watch Video
By John Fox, MD; Michael Kolodziej, MD; Bryan Loy, MD, MBA; Steven Peskin, MD, MBA, FACP; Burt Zweigenhaft, PhD, D.Litt
Issues surrounding healthcare insurance continue to unfold in light of the recent COVID-19 pandemic. In this discussion, a panel of managed care experts, moderated by Michael Kolodziej, MD, explore strategies for reducing the total cost of care for patients with cancer and addressing the economic and administrative burdens that practices and payers are facing as a result of the crisis.
Watch Video
Watch Video